Predicting Anatomical Urological Abnormalities in Children Who Present With Their First Urinary Tract Infection

Carregando...
Imagem de Miniatura
Citações na Scopus
2
Tipo de produção
article
Data de publicação
2013
Título da Revista
ISSN da Revista
Título do Volume
Editora
Autores
ZANETTA, Vitor C.
ROSMAN, Brian M.
ROWE, Courtney K.
BUONFIGLIO, Helena B.
YU, Richard N.
NGUYEN, Hiep T.
Citação
CLINICAL PEDIATRICS, v.52, n.8, p.739-746, 2013
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objectives. Classically, presence of fever 38.0 degrees C is used to distinguish pyelonephritis from cystitis. We analyzed whether this is an appropriate marker to initiate further workup and whether temperature is correlated with urological abnormalities and further surgical or pharmacological intervention. Methods. Children who presented for their first workup of urinary tract infection between October 1, 2008, and September 30, 2009 were retrospectively selected from our institution. Demographics and clinical details were correlated with the diagnosis of urological abnormalities and requirement for intervention. Results. Age was the most important variable to predict urological abnormalities. The temperature value of 38.3 degrees C maximized the balance between sensitivity (90%) and specificity (46%) for predicting the need to intervene and the presence of anatomical urological abnormalities. Conclusion. Young age (2 years) and temperature are the best factors to predict further intervention and urological abnormalities, with a temperature value of 38.3 degrees C being a better predictive value than the currently used 38.0 degrees C.
Palavras-chave
urinary tract infection, children, vesicoureteral reflux, fever
Referências
  1. Biggi A, 2001, PEDIATR NEPHROL, V16, P733
  2. FAIRLEY KF, 1971, LANCET, V2, P615
  3. Finnell SME, 2011, PEDIATRICS, V128, P749, DOI 10.1542/peds.2011-1332
  4. Gilani KA, 2010, INT UROL NEPHROL, V42, P1041, DOI 10.1007/s11255-009-9650-x
  5. Gorelick MH, 2000, ARCH PEDIAT ADOL MED, V154, P386
  6. Griebling TL, 2005, J UROLOGY, V173, P1288, DOI 10.1097/01.ju.0000155595.98120.8e
  7. Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010
  8. HOBERMAN A, 1993, J PEDIATR-US, V123, P17, DOI 10.1016/S0022-3476(05)81531-8
  9. Kallen Ronald, 2003, N Engl J Med, V348, P1812
  10. Karram M, 2008, OSTERGARDSS UROGYNEC, P148
  11. Koyle MA, 2011, PEDIATR SURG INT, V27, P337, DOI 10.1007/s00383-011-2863-y
  12. Krzemien G, 2004, MED SCI MONITOR, V10, pCR593
  13. Lane DR, 2011, EMERG MED CLIN N AM, V29, P539, DOI 10.1016/j.emc.2011.04.001
  14. MACKOWIAK PA, 1992, JAMA-J AM MED ASSOC, V268, P1578, DOI 10.1001/jama.268.12.1578
  15. MACKOWIAK PA, 1995, SOUTHERN MED J, V88, P934, DOI 10.1097/00007611-199509000-00009
  16. Marild S, 1998, ACTA PAEDIATR, V87, P549, DOI 10.1080/08035259850158272
  17. Montini G, 2011, NEW ENGL J MED, V365, P239, DOI 10.1056/NEJMra1007755
  18. Rahn DD, 2011, J CLIN EPIDEMIOL, V64, P293, DOI 10.1016/j.jclinepi.2010.03.017
  19. Raszka WV, 2005, PEDIATR REV, V26, P364, DOI 10.1542/pir.26-10-364
  20. Schmiemann G, 2010, DTSCH ARZTEBL INT, V107, P361, DOI 10.3238/arztebl.2010.0361
  21. Shaikh N, 2008, PEDIATR INFECT DIS J, V27, P302, DOI 10.1097/INF.0b013e31815e4122
  22. Shaw KN, 1998, PEDIATRICS, V102, part. no., DOI 10.1542/peds.102.2.e16
  23. Subcommittee on Urinary Tract Infection Steering Committee on Quality Improvement Management Roberts KB, 2011, PEDIATRICS, V128, P595
  24. [Anonymous], PEDIATRICS, V201, P595
  25. [Anonymous], 2004, PEDIATRICS, V114, P874